KOSDAQElectronic Components038460

BioSmart

₩2,210▼ 1.56%2026-11-18 close
Market Cap
₩55.9B
Turnover
₩86,309,395
Volume
40K
Shares out.
25.3M
PER
4.2×
PBR
0.3×
EPS
₩532
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Profit recovery continues, but net income swings remain the issue

Operating profit rose in 2024 and 2025, and revenue has grown for three straight quarters through the third quarter of 2026, yet net income attributable to controlling shareholders still swings sharply from quarter to quarter.

  1. 1

    BioSmart's operating profit reached KRW 22.6 billion in 2025, up 11.5% year on year, with an operating margin of 4.7%.

  2. 2

    Third-quarter 2026 revenue was KRW 170.9 billion, up 36.1% from a year earlier.

  3. 3

    Net income attributable to controlling shareholders fell to KRW 127 million in 2024 before recovering to KRW 9.01 billion in 2025.

  4. 4

    Net income attributable to controlling shareholders was KRW 3.98 billion in the third quarter of 2026, up from KRW 1.05 billion in the second quarter, but quarterly volatility remains large.

  5. 5

    In March 2026, 889,896 treasury shares were retired, worth about KRW 3.7 billion as of March 27.

02

Business structure

BioSmart manufactures smart cards as a specialist credit card manufacturer and also runs a business in equipment and solutions used to build card issuance systems. Under sector classification, it falls within electronic components manufacturing in the KOSDAQ electrical and electronics group.

The company also plays a holding-company-type role, so the results of its group affiliates are included in its consolidated financial statements. The group's chairman has pursued growth through mergers and acquisitions, a strategy that has expanded revenue scale.

The same strategy has also made the group's valuation a point of debate, since the share prices of some listed affiliates have fallen sharply. Demand for smart cards and issuance equipment tends to depend on when card companies and financial institutions invest in their systems, so quarterly revenue can be uneven.

For that reason, the more reliable way to read results is through the direction of quarterly revenue and changes in operating margin. Compared with large listed electronic component makers such as Samsung Electro-Mechanics and LG Innotek, BioSmart's business scope and size differ, which limits direct comparison.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩125.5B₩7.6B6.1%
2025Q4₩124.2B₩5.1B4.1%
2026Q1₩145.3B₩10.1B6.9%
2026Q2₩167.6B₩5.1B3.1%
2026Q3₩170.9B₩8.3B4.9%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩391.8B₩10.2B₩700M2.6%0.7%157.0%
2023₩456.2B₩10.1B₩17.9B2.2%16.0%113.8%
2024₩484.3B₩20.2B₩100M4.2%0.1%68.0%
2025₩482.8B₩22.6B₩9B4.7%6.3%65.1%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-18

04

Earnings analysis

Annual revenue rose from KRW 391.8 billion in 2022 to KRW 456.2 billion in 2023 (up 16.4% year on year) and KRW 484.3 billion in 2024 (up 6.2%), then edged down to KRW 482.8 billion in 2025 (down 0.3%). Among 2022 to 2025, 2024 was the largest year for revenue.

Operating profit stayed flat at KRW 10.2 billion in 2022 and KRW 10.1 billion in 2023 (down 0.6%), then rose to KRW 20.2 billion in 2024 (up 100.6%) and KRW 22.6 billion in 2025 (up 11.5%), increasing for two consecutive years.

Operating margin climbed from 2.6% in 2022 and 2.2% in 2023 to 4.2% in 2024 and 4.7% in 2025. In 2025, operating profit grew 11.5% even as revenue slipped 0.3%, so margin improvement rather than top-line growth drove earnings.

Net income attributable to controlling shareholders jumped from KRW 721 million in 2022 to KRW 17.9 billion in 2023 (up 2,382.6%).

However, that 2023 figure was well above operating profit of KRW 10.1 billion, and according to Korea Economic Daily financial data, non-operating income rose to about KRW 26.9 billion that year, which appears to explain much of the gap.

In 2024, net income attributable to controlling shareholders fell to KRW 127 million (down 99.3%), in contrast to the rise in operating profit. It recovered to KRW 9.01 billion in 2025 (up 6,984.2%).

Net income including non-controlling interests was a net loss of KRW 1.18 billion in 2022, then KRW 16.2 billion in 2023, KRW 1.06 billion in 2024, and KRW 8.99 billion in 2025, a different path from net income attributable to controlling shareholders.

On a quarterly basis, Thinkpool described third-quarter 2025 operating profit of KRW 7.63 billion as the highest in three years.

Operating profit then reached KRW 5.14 billion in the fourth quarter of 2025 (down 32.7% from the prior quarter), KRW 10.1 billion in the first quarter of 2026 (up 96.1%), KRW 5.12 billion in the second quarter (down 49.2%), and KRW 8.29 billion in the third quarter (up 62.1%, and up 8.7% year on year), so swings were large.

The second quarter of 2026 stands out because operating profit of KRW 5.12 billion came with net income attributable to controlling shareholders of only KRW 1.05 billion, a wide gap between the two measures.

Net income attributable to controlling shareholders totaled KRW 13.5 billion over the last four quarters, from the fourth quarter of 2025 through the third quarter of 2026.

05

Industry analysis

Smart cards and card issuance equipment, BioSmart's core areas, are tied to when card companies and financial institutions replace their systems, so orders tend to concentrate in particular periods. That is why quarterly revenue can swing sharply.

Revenue rising for three straight quarters in 2026 may partly reflect this ordering pattern. In Alphasquare's comparison of the electronic equipment and devices sector on a 2025 full-year basis, BioSmart's operating margin of 4.67% sat well above the sector average.

That average, however, is pulled down by loss-making companies, so direct comparison requires caution. Samsung Electro-Mechanics and LG Innotek are large players within global component supply chains, with different business scale and profit structures, which makes them difficult direct comparables for BioSmart.

On growth, revenue dipped slightly in 2025, so the pace of top-line expansion has been modest relative to the recovery in margins.

Some observers argue that the group's listed companies have long traded at a discount to their asset value, and Dealsite reported that the group's acquisition-driven growth model is being tested. Whether shareholder return policy shifts is seen as a factor that could separate BioSmart's standing within the sector.

06

Outlook

The most concrete shareholder return move confirmed in filings and press coverage is the treasury share retirement in March 2026. According to Dealsite, 889,896 treasury shares, worth about KRW 3.7 billion as of March 27, 2026, were fully retired.

Dealsite described this as a first step beyond the group's previously passive return policy and reported that the market reads it as an early signal of strategic change. On results, third-quarter 2026 revenue of KRW 170.9 billion rose 36.1% year on year, so the expansion trend has continued.

Operating profit was KRW 10.1 billion in the first quarter and KRW 8.29 billion in the third quarter, but only KRW 5.12 billion in the second quarter, leaving quarterly variation wide.

Net income attributable to controlling shareholders recovered to KRW 3.98 billion in the third quarter, yet compared with KRW 1.05 billion in the second quarter it is hard to call the pattern stable.

A debt-to-equity ratio of 65.1% and operating cash flow of KRW 24.1 billion at the end of 2025 provide the financial basis that could support investment and shareholder returns. Fourth-quarter 2026 results have not yet been filed in a periodic report, and the next periodic report is the 2026 annual report.

The next checkpoints are whether the operating margin in the 2026 annual report exceeds 4.7%, and whether net income attributable to controlling shareholders holds near the KRW 13.5 billion four-quarter total.

07

Valuation

PER
4.2×
PBR
0.3×
ROE
8.9%
EPS
₩532
BPS
₩6,408
Dividend per share
₩0

Measured against net assets, the price-to-book ratio at year-end was below 1 times in every year from 2022 onward. In other words, the market has valued the company at a level below the book value of its controlling shareholders' equity of about KRW 144 billion.

A price-to-book ratio under 1 times alone does not settle a valuation, because the earnings power of the assets, operating margin, and discounts tied to the group structure all matter.

On earnings, net income attributable to controlling shareholders fell into the low hundreds of millions of won in 2024, which pushed the year-end price-earnings multiple to an unusually high level, and after the 2025 recovery the multiple became interpretable again.

Past multiples have swung widely with earnings, so no single multiple explains the valuation on its own. The dividend yield sits below the sector average, which leaves treasury share retirement as the main form of shareholder return for now.

Net income attributable to controlling shareholders totaled KRW 13.5 billion over the last four quarters, a modest scale relative to controlling shareholders' equity of about KRW 144 billion.

Any change in how the valuation reads would depend on the direction of operating margin and controlling-shareholder net income, which the upcoming periodic reports will show.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-18

08

Bull factors

Recovery in operating profit

Operating profit rose for two consecutive years to KRW 20.2 billion in 2024 and KRW 22.6 billion in 2025, and operating margin improved from 2.6% in 2022 to 4.7% in 2025. Operating profit grew 11.5% in 2025 even as revenue slipped 0.3%, which shows that margin gains drove earnings. Third-quarter 2026 operating profit of KRW 8.29 billion was up 8.7% year on year.

Expanding revenue base

Revenue reached KRW 145.3 billion in the first quarter of 2026, KRW 167.6 billion in the second, and KRW 170.9 billion in the third, rising for three consecutive quarters. Third-quarter revenue was up 36.1% from a year earlier. The fourth quarter of 2025 was the low point, so the recovery has continued on a quarterly basis.

Shareholder return signal and stronger balance sheet

BioSmart retired 889,896 treasury shares in March 2026, worth about KRW 3.7 billion as of March 27. Dealsite described this as a first step beyond the group's passive return approach. The debt-to-equity ratio fell from 157.0% in 2022 to 65.1% in 2025, and operating cash flow rose to KRW 24.1 billion in 2025.

09

Bear factors

Large swings in net income attributable to controlling shareholders

Net income attributable to controlling shareholders was KRW 17.9 billion in 2023, KRW 127 million in 2024, and KRW 9.01 billion in 2025, varying widely each year. In the second quarter of 2026, it was KRW 1.05 billion against operating profit of KRW 5.12 billion, down 77.4% from the prior quarter. In some years, operating profit gains did not carry through to net income.

Stagnant revenue and thin margins

Revenue fell 0.3% to KRW 482.8 billion in 2025, and fourth-quarter 2025 revenue dropped 1.0% from the prior quarter. The operating margin of 4.7% has improved but remains in the low single digits. With revenue flat, profit gains rely on cost control, which raises questions about sustainability.

Group structure and valuation debate

Dealsite assessed that the group's listed companies have traded at a long-running discount and that its acquisition-led growth formula has reached its limits. It also reported that some listed affiliates in the group fell to the low KRW 1,000 range.

Results have held up, but there is a view that the company has not fully responded to demands for higher corporate value.

10

Risk factors

Business structure and order timing

Demand for smart cards and issuance equipment depends on when card companies and financial institutions invest, so quarterly revenue may be uneven. In the second quarter of 2026, revenue rose while operating profit fell to KRW 5.12 billion. The causes of margin swings are difficult to pin down quarter by quarter, which adds to the risk.

Non-operating items and the link to net income

According to Korea Economic Daily financial data, non-operating income was about KRW 26.9 billion in 2023, exceeding operating profit and lifting net income, then fell to about KRW 10.9 billion in 2024 and about KRW 3.7 billion in 2025.

As non-operating items shrank, the link between operating profit and net income attributable to controlling shareholders weakened. Net income direction is harder to read from operating results alone.

Group dependence and trading liquidity

The group's control structure and reliance on M&A make its evaluation sensitive to how acquired affiliates perform. According to Alphasquare, trading value on September 23, 2026 was about KRW 225.64 million. In thinly traded stocks, even small orders can move the share price significantly.

11

What to watch next

  1. February 2027 (expected timing of the annual preliminary results)

    Fourth-quarter 2026 and full-year 2026 preliminary results will be released. The key is whether fourth-quarter net income attributable to controlling shareholders stays in line with the KRW 13.5 billion four-quarter total.

  2. End of March 2027 (filing deadline for the 2026 annual report)

    Full-year 2026 operating margin, debt-to-equity ratio, and operating cash flow will be confirmed in the periodic report. The checkpoint is whether the operating margin exceeds the 4.7% recorded in 2025.

  3. March 2027 (typical timing of the regular shareholders' meeting)

    Whether further shareholder return measures or a dividend policy is set after the treasury share retirement. This will show whether the March 2026 retirement was a one-off or part of a policy shift.

  4. Mid-May 2027 (filing deadline for the first-quarter 2027 report)

    First-quarter 2027 revenue and operating profit will be compared with KRW 145.3 billion and KRW 10.1 billion in the first quarter of 2026. The size of quarterly net income swings will also be tracked.

12

Overall view

BioSmart's operating profit rose for two consecutive years to KRW 22.6 billion in 2025, and its operating margin climbed to 4.7%, showing a recovery in operating strength. Revenue has grown for three straight quarters through the third quarter of 2026, with third-quarter revenue up 36.1% year on year.

Net income attributable to controlling shareholders, however, moved from KRW 127 million in 2024 to KRW 9.01 billion in 2025, and fell to KRW 1.05 billion in the second quarter of 2026, so quarterly volatility remains high.

Net income in 2023 was heavily influenced by non-operating income, which makes the link between operating profit and net income a central point of interpretation.

The March 2026 treasury share retirement is read as a signal of a shift in shareholder returns, but whether it becomes a policy will be confirmed through upcoming periodic reports and shareholder meetings.

On valuation, the price-to-book ratio at year-end has been below 1 times since 2022, and discounts tied to the group structure are often cited. Strengths and weaknesses both exist, so a one-sided conclusion is hard to justify.

The next checkpoints are the operating margin and the direction of net income attributable to controlling shareholders in the 2026 annual report.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 15 more articles and sources
  1. kokstock.com
  2. m.finance.daum.net
  3. finance.finup.co.kr
  4. investing.com
  5. valueline.co.kr
  6. markets.hankyung.com
  7. daramtickers.com
  8. pmstoryhub.com
  9. m.thinkpool.com
  10. comp.fnguide.com
  11. jobkorea.co.kr
  12. judal.co.kr
  13. alphasquare.co.kr
  14. datatooza.com
  15. dealsite.co.kr

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis